X

Market News

Bilibili posts narrower-than-expected loss in Q2

Bilibili Inc. (NASDAQ: BILI) reported a wider loss in the second quarter due to higher costs and expenses. The bottom…

Earnings preview: What to expect when American Outdoor Brands reports Q1 results

American Outdoor Brands Corporation (NASDAQ: AOBC) is slated to report first quarter 2020 earnings results on Thursday, August 29, after…

Pot giants gain on DEA announcement; GW Pharmaceuticals continues to decline

Marijuana giants received a major boost on Monday after the US Drug Enforcement Administration (DEA) announced that it would initiate…

Earnings preview: Ulta Beauty set to charm the market with solid Q2 results

Cosmetics retailer Ulta Beauty, Inc. (Nasdaq: ULTA) was successful in beating the general weakness the industry witnessed last year. It…

Earnings preview: How will Q2 turn out for Dollar General?

Dollar General Corporation (NYSE: DG) is slated to report second quarter 2019 earnings results on Thursday, August 29, before the…

Why Arbutus Biopharma stock dipped to 11-year low?

Arbutus Biopharma Corporation (NASDAQ: ABUS) stock plunged to an 11-year low of $1.31 on Monday due to considerable downside risk…

Earnings preview: Q2 results may set the tone for Dollar Tree’s turnaround

Though supermarket chain Dollar Tree (NASDAQ: DLTR) had a weak start to 2019, the recovery of its Family Dollar segment…

Earnings preview: Will Best Buy have a new roadmap in Q2?

Best Buy Co. Inc. (NYSE:BBY) is slated to report second quarter 2020 earnings results on Thursday, August 29, before the…

Market bullish as Workday heads towards Q2 earnings

Workday (Nasdaq: WDAY) will report second-quarter 2020 financial results after the regular trading hours on Thursday, August 29. The market…

Amgen to take over Celgene’s OTEZLA for $13.4 billion; Bristol-Myers Squibb increases share buyback plan

Bristol-Myers-Squibb (NASDAQ: BMY) announced that Amgen (NASDAQ: AMGN) will acquire Celgene’s (NASDAQ: CELG) Otezla business for $13.4 billion in a…